1Suzuki H,Mofi M ,Kawaguchi C,et al. Serum vescular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma[J]. Int J Oncol,1999,14(6):1 087-1 090. 被引量：1
2Kraft A ,Weindel K,Ochs A ,et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[ J ]. Cancer, 1999,85 ( 1 ) : 178 - 187. 被引量：1
3Sumiyoshi Y, Yamashita Y, Maekawa T, et al. Expression of CD44, vascular endothelial growth factor,and proliferating cell nuclear antigen in severe venous invasional colorectal cancer and its relationship to liver metastasis[ J]. Surg Today ,2000,30(4) :323 -337. 被引量：1
6Kouromalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut,1998,42:442-447. 被引量：1
7Mentlein R, Eichler O, Forstre F, et al. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells. Int J Cancer,2001,92:545-550. 被引量：1
8Cascinu S, Del Ferro E, Ligi M, et al. Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients. Cancer Invest,2001,19:8-12. 被引量：1
9Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med,1996,2:461-462. 被引量：1
10Dirix L Y, Vermeulen P B, Hubens L, et al. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer[J]. Ann Oncol,1996,7(3): 843-848. 被引量：1
